David Sirota asks, “Will Big Pharma Fleece Us On A COVID Treatment That We Helped Fund?“

This has been another episode of simple answers to simple questions.

On a more serious notes, extreme rent seeking is arguably the central tenet of the US economy these days.

If Remdesivir proves to be a good treatment for Covid-19, it will be sold for tens, if not hundreds, of times the cost of manufacture, and most of the development of the drug was paid for by the taxpayers.